A UK general practice population cohort study investigating the association between lipid lowering drugs and 30-day mortality following medically attended acute respiratory illness
Background. Cholesterol lowering drugs HMG-CoA reductase inhibitors (statins) and PPARα activators (fibrates) have been shown to reduce host inflammation via non-disease specific immunomodulatory mechanisms. Recent studies suggest that commonly prescribed drugs in general practice, statins and fibra...
Main Authors: | Roshni Joshi, Sudhir Venkatesan, Puja R. Myles |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2016-04-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/1902.pdf |
Similar Items
-
Combined statin-fibrate therapy-induced rhabdomyolysis: Case report
by: Jozić Tanja L., et al.
Published: (2014-01-01) -
Biochemical changes associated with the fermentation of baobab seeds in Maari: An alkaline fermented seeds condiment from western Africa
by: Charles Parkouda, et al.
Published: (2015-06-01) -
Elucidating the Effects of the Lipids Regulators Fibrates and Statins on the Health Status of Finfish Species: A Review
by: Manuel Blonç, et al.
Published: (2023-02-01) -
Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies
by: Magda Dubińska-Magiera, et al.
Published: (2021-05-01) -
Some of Cohesion tools in Al-Maari poetry (ghair mojden)
by: Mamoun Mbarka
Published: (2021-01-01)